As of November 2024, Medigene has a market cap of $63.34M. This makes Medigene the world's 23837th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $43.27M | 3.93% |
2023 | $41.63M | -24.50% |
2022 | $55.15M | -29.49% |
2021 | $78.22M | -18.61% |
2020 | $96.10M | -12.00% |
2019 | $109.20M | -45.80% |
2018 | $201.48M | -42.03% |
2017 | $347.54M | 6.97% |
2016 | $324.88M | 36.80% |
2015 | $237.49M | 133.66% |
2014 | $101.64M | 6.37% |
2013 | $95.55M | -12.76% |
2012 | $109.53M | 3.40% |
2011 | $105.93M | -51.26% |
2010 | $217.32M | -44.41% |
2009 | $390.95M | -16.74% |
2008 | $469.58M | -19.63% |
2007 | $584.24M | -23.24% |
2006 | $761.15M | -16.63% |
2005 | $912.95M | -1.65% |
2004 | $928.23M | 42.38% |
2003 | $651.95M | 51.14% |
2002 | $431.36M | -81.23% |
2001 | $2.30B | -71.43% |
2000 | $8.04B | - |